Keeping in view the direct relationship between endothelial dysfunction and atherosclerosis, the diseased status of endothelium is directly involved in the pathophysiology of various cardiovascular disorders
including hypertension, inflammation, generation of reactive oxygen species (ROS), oxidative stress and other vascular abnormalities such as coronary heart disease and pulmonary hypertension.
Accumulating evidences confirm the feasibility of using herbal preparations and herbal medical products in the treatment or prevention of cardiovascular disorders
. Saleh Al-Shehabi et al.
She added: "In Western Europe meat in general and beef and veal in particular continued to decline by 0.3% and to c de 1% respectively amidst mounting health concerns linking red meat to cardiovascular disorders
and colon cancer.
Increasing prevalence of cardiovascular disorders
and expanding aging demographics are the major drivers for the growth of global cardiovascular needle market.
This evidence provided up to this point clearly indicates that the level of HbAlc increases among the untreated diabetics with cardiovascular disorders
, particularly ischemic heart disease (IHD) and stroke are globally the number 1 cause of death and contribute globally to 1/3 and in many countries 1/2 of total mortality .
Ranbaxy, which makes ingredients at the plants for drugs used in oncology, dermatology, gastrointestinal and cardiovascular disorders
, generated 36 per cent of its sales in the US in the quarter ending in December.
An earlier clinical trial of testosterone therapy in older men that included many men with cardiovascular disorders
was halted early after an increase in cardiovascular events in the testosterone group compared with the placebo group was found, the National Institutes of Health reported in 2010.
Along with the burgeoning elderly population comes an increase in cardiovascular disorders
. While clinical trials focusing on older adults are increasing, there has been limited data on people 85 and above, and the need for customized care, particularly for those with coexisting conditions.
The majority of key risk factors related to other major cardiovascular disorders
(for example, smoking, diabetes, high blood pressure and high cholesterol) is the same for PAD, and all are treatable and preventable.
BIND Therapeutics is discovering and developing Accurins, proprietary new best-in-class therapeutics with superior target selectivity and the potential to improve patient outcomes in the areas of oncology, inflammatory diseases and cardiovascular disorders
. Leveraging its proprietary Medicinal Nanoengineering platform, BIND develops Accurins that outperform conventional drugs by selectively accumulating in diseased tissues and cells.
(CVD) are the number one cause of death globally.